SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-006826
Filing Date
2018-10-23
Accepted
2018-10-23 16:12:51
Documents
4
Period of Report
2018-12-12
Effectiveness Date
2018-10-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2236965zdef14a.htm DEF 14A 478088
2 G111573.JPG g111573.jpg GRAPHIC 5681
3 G365892BCI001.JPG g365892bci001.jpg GRAPHIC 119502
4 G365892BCI002.JPG g365892bci002.jpg GRAPHIC 111785
  Complete submission text file 0001047469-18-006826.txt   805830
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 181134271
SIC: 2834 Pharmaceutical Preparations